Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs

Journal of Biomedical Nanotechnology

Volumn 7, Issue 4, 2011, Pages 489-503

  Singh, Ravina ^a   Nalwa, Hari Singh ^b  

^a West Ranch High School   (United States)

^b Nanomax Technologies   (United States)

Author keywords

Anticancer nanodrugs; Antimicrobial agents; Cell labeling; Contrast agents for biological imaging; Cosmetics; Medical applications; Nanoparticles; Nanotoxicology

Indexed keywords

ANTI-MICROBIAL AGENT; ANTICANCER NANODRUGS; CELL LABELING; CONTRAST AGENT; COSMETICS; NANOTOXICOLOGY;

BIOLOGICAL MATERIALS; CARBON NANOTUBES; CYTOLOGY; DIAGNOSIS; DISEASES; DRUG DELIVERY; MEDICAL APPLICATIONS; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; MICROORGANISMS; NANORODS; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; NANOWIRES;

NANOPARTICLES;

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE MACROGOL; BIOLOGICAL MARKER; CARBON NANOTUBE; CONTRAST MEDIUM; DAUNORUBICIN; DENILEUKIN DIFTITOX; DOXORUBICIN; FLOXURIDINE; FLUORESCENT DYE; FLUORESCENT MAGNETIC NANOPARTICLE; FULLERENE DERIVATIVE; GADOLINIUM; GOLD NANOPARTICLE; IRINOTECAN; LANTHANUM; LANTHANUM CALCIUM MANGANATE; NANOPARTICLE; NANOROD; NANOWIRE; PACLITAXEL; QUANTUM DOT; RUTHENIUM; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; THIOGUANINE CAPPED GOLD NANOPARTICLE; TIOGUANINE; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; ZINOSTATIN; COSMETIC; DIAGNOSTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CANDIDA ALBICANS; CELL LABELING; CELL VIABILITY; CHEMICAL MODIFICATION; CONTRAST ENHANCEMENT; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; IMAGING; MICROCOCCUS LUTEUS; MITOSIS INHIBITION; MOLECULAR IMAGING; NANOTECHNOLOGY; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); PROCEDURES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; CYTOLOGY; DIAGNOSTIC IMAGING; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; COSMETICS; CYTOLOGICAL TECHNIQUES; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 80052893655     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1324     Document Type: Article

References (149)

1. R. Feynman, There's Plenty of Room at the Bottom, Caltech Institute Archives, Pasadena, California (1959).
2. 60: Buckminsterfullerene. Nature 318, 162 (1985).
3. H. S. Nalwa (ed.), Handbook of Nanostructured Materials and Nanotechnology, Academic Press, San Diego (2000), Vols. 1-5.
4. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles (2004), Vols. 1-10.
5. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles (2011), Vols. 11-25.
6. H. S. Nalwa (ed.), Polymeric Nanostructures and Their Applications, American Scientific Publishers, Los Angeles (2007), Vols. 1-2.
7. H. S. Nalwa (ed.), Handbook of Organic Electronics and Photonics, American Scientific Publishers, Los Angeles (2008), Vols. 1-3.
8. H. S. Nalwa (ed.), Nanomaterials for Energy Storage Applications, American Scientific Publishers, Los Angeles (2009).
9. H. S. Nalwa (ed.), Soft Nanomaterials, American Scientific Publishers, Los Angeles (2009), Vols. 1-2.
10. H. S. Nalwa (ed.), Magnetic Nanostructures, Second Edition, American Scientific Publishers, Los Angeles (2009).
11. T.-Y. Tseng and H. S. Nalwa (eds.), Handbook of Nanoceramics and Their Based Nanodevices, American Scientific Publishers, Los Angeles (2009), Vols. 1-5.
12. K. Ariga and H. S. Nalwa (eds.), Bottom-Up Nanofabrication- Supramolecules, Self-Assemblies, and Organized Films, American Scientific Publishers, Los Angeles (2009), Vols. 1-6.
13. H. S. Nalwa (ed.), Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology, American Scientific Publishers, Los Angeles (2005), Vols. 1-2.
14. N. He and H. S. Nalwa (eds.), Biochips Nanotechnology, American Scientific Publishers, Los Angeles (2009).
15. S. Ilbasmis-Tamer, S. Yilmaz, E. Banoglu, and I. T. Degim, Carbon nanotubes to deliver drug molecules. J. Biomed. Nanotechnol. 6, 20 (2010).
16. H. S. Nalwa and T. Webster (eds.), Cancer Nanotechnology - Nanomaterials for Cancer Diagnosis and Therapy, American Scientific Publishers, Los Angeles (2007).
17. S. Singh, Nanomedicine-nanoscale drugs and delivery systems. J. Nanosci. Nanotechnol. 10, 7906 (2010).
18. K. Y. Kim, Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine, 2,103 (2007).
19. D. P. Mohapatra, F. Gassara, and S. K. Brar, Nanoparticles-production and role in biotransformation, J Nanosci Nanotechnol. 11, 899 (2011).
20. R. A. Rippel and A. M. Seifalian, Gold revolution-gold nanoparticles for modern medicine and surgery. J. Nanosci. Nanotechnol. 11, 3740 (2011).
21. B. Sitharaman and L. J. Wilson, Gadofullerenes and gadonanotubes: A new paradigm for high-performance magnetic resonance imaging contrast agent probes. J. Biomed. Nanotechnol. 3, 342 (2007);
22. x: Nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution. Nano Lett. 4, 2373 (2004).
23. D. Zhu, R. D. White, P. A. Hardy, N. Weerapreeyakul, K. Sutthanut, and M. Jay, Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: Stability and relaxivity of a potential MRI contrast agent. J. Nanosci. Nanotechnol. 6, 996 (2006).
24. (a) R. D. Bolskar, Gadofullerene MRI contrast agents. Nanomedicine 3, 201 (2008);
25. 2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. Nanomedicine, Nanotechnol., Biol., Med. 3, 201 (2008).
26. K. B. Hartman, S. Laus, R. D. Bolskar, R. Muthupillai, L. Helm, E. Toth, A. E. Merbach, and L. J. Wilson, Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett. 8, 415 (2008).
27. C. Kojima, Y. Umeda, M. Ogawa, A. Harada, Y. Magata, and K. Kono, X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticle in PEGylated dendrimer. Nanotechnology 21, 245104 (2010).
28. L. Tong, Q. Wei, A. Wei, and J. X. Cheng, Gold nanorods as contrast agents for biological imaging: Surface conjugation, twophoton luminescence, and photothermal effects. Photochem. Photobiol. 85, 21 (2009).
29. C. R. Patra, R. Bhattacharya, S. Patra, S. Basu, P. Mukherjee, and D. Mukhopadhyay, Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J. Nanobiotechnol. 4, 11 (2006);
30. C. R. Patra, R. Bhattacharya, S. Patra, S. Basu, P. Mukherjee, and D. Mukhopadhyay, Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clinical Chem. 53, 2029 (2007).
31. A. Retnakumari, S. Setua, D. Menon, P. Ravindran, H. Muhammed, T. Pradeep, S. Nair, and M. Koyakutty, Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology 21, 055103 (2010).
32. S. S Banerjee and D.-H. Chen, Multifunctional pH-sensitive magnetic nanoparticles for simultaneous imaging, sensing and targeted intracellular anticancer drug delivery. Nanotechnology 19, 505104 (2008).
33. M. Nowostawska, S. A. Corr, S. J. Byrne, J. Conroy, Y. Volkov, and Y. K. Gun'ko, Porphyrin-magnetite nanoconjugates for biological imaging. J. Nanobiotechnol. 9, 13 (2011).
34. X. Yi, Y. Ding, Y. Zeng, C. Zhou, B. Luo, S. Meng, W. Rui, Y. Zhao, and W. Li, Magnetic resonance imaging contrast agent: cRGD-Ferric oxide nanometer particle and Its role in the diagnosis of tumor. J. Nanosci. Nanotechnol. 11, 3800 (2011).
35. W. Chen, Nanoparticle fluorescence based technology for biological applications. J. Nanosci. Nanotechnol. 8, 1019 (2008).
36. P. Suriamoorthy, X. Zhang, G. Hao, A. G. Joly, S. Singh, M. Hossu, X. Sun, and W. Chen, Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting. Cancer Nanotechnol. 1, 19 (2010).
37. R. Weissleder, A clearer vision for in vivo imaging. Nat. Biotechnol. 19, 316 (2001).
38. V. Ntziachristos, C. Bremer, and R. Weissleder, Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195 (2003).
39. R. Kumar, I. Roy, T. Y. Ohulchanskky, L. A. Vathy, E. J. Bergey, M. Sajjad, and P. N. Prasad, In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699 (2010).
40. E. I. Altinoglu, T. J. Russin, J. M. Kaiser, B. M. Barth, P. C. Eklund, M. Kester, and J. H. Adair, Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2, 2075 (2008).
41. D. J. Maxwell, J. Bonde, D. A. Hess, S. A. Hohm, R. Lahey, P. Zhou, M. H. Creer, D. Piwnica-Worms, and J. A. Nolta, Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells 26, 517 (2008).
42. 4 nanoparticles and their applications in cell labeling and in vivo imaging. J. Nanobiotechnol. 8, 25 (2010).
43. F. Bertorelle, C. Wilhelm, J. Roger, F. Gazeau, C. Menager, and V. Cabuil, Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging. Langmuir 22, 5385 (2006).
44. C. Wilhelm and F. Gazeau, Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161 (2008).
45. H. Terazono, Y. Anzai, M. Soloviev, K. Yasuda, Labelling of live cells using fluorescent aptamers: binding reversal with DNA nucleases. J. Nanobiotechnol. 8, 8 (2010).
46. J. Ruan, J. Shen, Z. wang, J. Ji, H. Song, K. Wang, B. Liu, J. Li, and D. Cui, Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology. Int. J. Nanomedicine 6, 425 (2011).
47. C. L. Tseng, I. L. Shih, L. Stobinski, and F. H. Lin, Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging. Biomaterials 20, 5427 (2010).
48. Z. Shi, K. G. Neoh, E. T. Kang, B. Shuter, and S. C. Wang, Bifunctional Eu(3+)-doped Gd(2)O(3) nanoparticles as a luminescent and T(1) contrast agent for stem cell labeling. Contrast Media Mol. Imaging. 5, 105 (2010).
49. M. Babic, D. Horák, M. Trchová, P. Jendelová, K. Glogarová, P. Lesný, V. Herynek, M. Hájek, and E. Syková, Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem. 19, 740 (2008).
50. S. Chaleawlert-Umpon, V. Mayen, K. Manotham, and N. Pimpha, Preparation of iron oxide-entrapped chitosan nanoparticles for stem cell labeling. J. Biomater. Sci. Polym. Ed. 21, 1515 (2010).
51. H. S. Kim, S. Y. Oh, H. J. Joo, K. R. Son, I. C. Song, and W. K. Moon, The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed. 23, 514 (2010).
52. O. Faklaris, V. Joshi, T. Irinopoulou, P. Tauc, M. Sennour, H. Girard, C. Gesset, J. C. Arnault, A. Thorel, J. P. Boudou, P. A. Curmi, and F. Treussart, Photoluminescent diamond nanoparticles for cell labeling: Study of the uptake mechanism in mammalian cells. ACS Nano. 3, 3955 (2009).
53. A. M. Reddy, B. K. Kwak, H. J. Shim, C. Ahn, H. S. Lee, Y. J. Shuh, and E. S. Park, In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticles using 3.0T MRI. J. Korean Med. Sci. 25, 211 (2010).
54. P. Smirnov, Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: Applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy. Methods Mol. Biol. 512, 333 (2009).
55. Y. Wang, Y. Wang, L. Wang, Y. Che, Z. Li, and D. Kong, Preparation and evaluation of magnetic nanoparticles for cell labeling. J. Nanosci. Nanotechnol. 11, 3749 (2011).
56. S. Chen, D. Alcantara, and L. Josephson, A magnetofluorescent nanoparticle for Ex-Vivo cell labeling by covalently linking the drugs protamine and feraheme. J. Nanosci. Nanotechnol. 11, 3058 (2011).
57. M. B. Zaman, T. N. Baral, Z. J. Jakubek, J. Zhang, X. Wu, E. Lai, D. Whitfield, and K. Yu, Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer. J. Nanosci. Nanotechnol. 11, 3757 (2011).
58. G. Xu, K.-T. Yong, I. Roy, and A. Kopwitthaya, FGF2-labeled semiconductor nanocrystals as luminescent biolabels for imaging neuroblastoma cells. J. Biomed. Nanotechnol. 6, 641 (2010).
59. V. Selvaraj, A. Nirmala Grace, M. Alagar, and I. Hamerton, Antimicrobial and anticancer efficacy of antineoplastic agent capped gold nanoparticles. J. Biomed. Nanotechnol. 6, 129 (2010).
60. W.-Y. Chen, J.-Y. Lin, W.-J. Chen, L. Luo, E. W. G. Diau, and Y.-C. Chen, Functional gold nanoclusters as antimicrobial agents for antibiotic-resistant bacteria. Nanomedicine 5, 755 (2010).
61. D. De, S. M. Mandal, S. S. Gauri, R. Bhattacharya, S. Ram, and S. K. Roy, Antibacterial effect of lanthanum calcium manganate (La0.67Ca0.33MnO3) nanoparticles against pseudomonas aeruginosa ATCC 27853. J. Biomed. Nanotechnol. 6, 138 (2010).
62. M. A. Syed, S. Babar, A. S. Bhatti, and H. Bokhari, Antibacterial effects of silver nanoparticles on the bacterial strains isolated from catheterized urinary tract infection cases. J. Biomed. Nanotechnol. 5, 209 (2009).
63. A. Tripathi, N. Chandrasekaran, A. M. Raichur, and A. Mukherjee, Antibacterial applications of silver nanoparticles synthesized by aqueous extract of azadirachta indica (neem) leaves. J. Biomed. Nanotechnol. 5, 93 (2009).
64. T. V. Sreekumar, A. Das, L. Chandra, A. Srivastava, and K. U. Bhasker Rao, Inherently colored antimicrobial fibers employing silver nanoparticles. J. Biomed. Nanotechnol. 5, 115 (2009).
65. K. Vasilev, V. R. Sah, R. V. Goreham, C. Ndi, R. D. Short, and H. J. Griesser, Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate- stabilized silver nanoparticles. Nanotechnology 21, 215102 (2010).
66. R. D. Holtz, A. G. Souza Filho, M. Brocchi, D. Martins, N. Durán, and O. L. Alves, Development of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agent. Nanotechnology 21, 185102 (2010).
67. V. C. Verma, R. N. Kharwar, and A. C. Gange, Biosynthesis of antimicrobial silver nanoparticles by the endophytic fungus Aspergillus clavatus. Nanomedicine 5, 33 (2010).
68. S. Pushpakanth, B. Srinivasan, T. P. Sastry, and A. B. Mandal, Biocompatible and antibacterial properties of silver-doped hydroxyapatite. J. Biomed. Nanotechnol. 4, 62 (2008).
69. J. Liao, M. Anchun, Z. Zhu, and Y. Quan, Antibacterial titanium plate deposited by silver nanoparticles exhibits cell compatibility. Int. J. Nanomedicine. 5, 337 (2010).
70. T. Kosaka, A. Ohgami, T. Nakamura, T. Ohana, and M. Ishihara, The preparation of Ag nanoparticle-modified single-walled carbon nanotubes and their antibacterial activity. Biocontrol. Sci. 14, 133 (2009).
71. R. R. Shah, S. Kaewgun, B. I. Lee, and T.-R. J. Tzeng, The antibacterial effects of biphasic brookite-anatase titanium dioxide nanoparticles on multiple-drug-resistant staphylococcus aureus. J. Biomed. Nanotechnol. 4, 339 (2008).
72. 2 Nanoparticles Co-doped with silver and nitrogen for antibacterial application. J. Nanosci. Nanotechnol. 10, 4868 (2010).
73. P. Joshi, S. Chakraborti, P. Chakrabarti, D. Haranath, V. Shanker, Z. A. Ansari, S. P. Singh, and V. Gupta, Role of surface adsorbed anionic species in antibacterial activity of zno quantum dots against escherichia coli. J. Nanosci. Nanotechnol. 9, 6427 (2009).
74. A. B. Mathur and Vishal Gupta, Silk fibroin-derived nanoparticles for biomedical applications. Nanomedicine 5, 807 (2010).
75. V. Gupta, A. Aseh, C. N. Rios, B. B. Aggarwal, and A. B. Mathur, Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int. J. Nanomed. 4, 115 (2009).
76. J. Kundu, Y. Chung, Y. H. Kim, G. Tae, and S. C. Kundu, Silk fibroin nanoparticles for cellular uptake and control release. Int. J. Pharm. 388, 242 (2010).
77. A. S. Gobin, R. Rhea, R. A. Newman, A. B. Mathur, Silk-fibroin-coated liposomes for long-term and targeted drug delivery. Int. J. Nanomed. 1, 81 (2006).
78. K.-K. Liu, W.-W. Zheng, C.-C. Wang, Y.-C. Chiu, C.-L. Cheng, Y.-S. Lo, C. Chen, and J.-I Chao, Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 21, 315106 (2010).
79. J. Conde, J. M. de la Fuente, and P. V. Baptista, RNA quantification using gold nanoprobes-application to cancer diagnostics. J. Nanobiotechnol. 8, 5 (2010).
80. G. Zhang, C. Wu, H. Ye, H. Yan, and X. Wang, Nanoscaled carborane ruthenium(II)-arene complex inducing lung cancer cells apoptosis. J. Nanobiotechnol. 9, 6 (2011).
81. N. Zhao, H. G. Bagaria, M. S. Wong, and Y. Zu, A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma. J. Nanobiotechnol. 9, 2 (2011).
82. H. H. Lara, N. V. Ayala-Nuñez, L. Ixtepan-Turrent, and C. Rodriguez-Padilla, Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 8, 1 (2010).
83. H. H Lara, L. Ixtepan-Turrent, E. N. Garza-Treviño, and C. Rodriguez-Padilla, PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture, J. Nanobiotechnol. 8, 15 (2010).
84. K. K. Jain, Advances in the field of nanooncology, BMC Med. 8, 83 (2010); K. K. Jain, PharmaBiotech, Basel, Switzerland.
85. G. Batist, K. A. Gelmon, K. N. Chi, W. H. Miller, Jr., S. K. Chia, L. D. Maye, C. E. Swenson, A. S. Janoff, and A. C. Louie, Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin. Cancer Res. 15, 692 (2009).
86. Y. Matsumura, M. Gotoh, K. Muro, Y. Yamada, K. Shirao, Y. Shimada, M. Okuwa, S. Matsumoto, Y. Miyata, H. Ohkura, K. Chin, S. Baba, T. Yamao, A. Kannami, Y. Takamatsu, K. Ito, and K. Takahashi, Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. Ann. Oncol. 15, 517 (2004).
87. L. W. Seymour, D. R. Ferry, D. J. Kerr, D. Rea, M. Whitlock, R. Poyner, C. Boivin, S. Hesslewood, C. Twelves, R. Blackie, A. Schatzlein, D. Jodrell, D. Bissett, H. Calvert, M. Lind, A. Robbins, S. Burtles, R. Duncan, and J. Cassidy, Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. Int. J. Oncol. 34, 1629 (2009).
88. K. E. Scarberry, E. B. Dickerson, Z. J. Zhang, B. B. Benigno, and J. F. McDonald, Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles. Nomedicine: Nanotechnol. Biol. Med. 6, 399 (2010).
89. X. Wang, X. Qian, J. J. Beitler, Z. G. Chen, F. R. Khuri, M. M. Lewis, H. J. C. Shin, S. Nie, and D. M. Shin, Detection of circulating tumor cells in human peripheral blood using surface-enhanced raman scattering nanoparticles. Cancer Res. 71, 1526 (2011).
90. H. Zheng, G. Chen, L. A. DeLouise, and Z. Lou, Detection of the cancer marker CD146 expression in melanoma cells with semiconductor quantum dot label. J. Biomed. Nanotechnol. 6, 303 (2010).
91. X. Wang, Y. Wang, Z. G. Chen, and D. M. Shin, Advances of cancer therapy by nanotechnology. Cancer Res. Treat. 41, 1 (2009).
92. R. Seigneuric, L. Markey, D. S. Nuyten, C. Dubernet, C. T. Evelo, E. Finot, and C. Garrido, From nanotechnology to nanomedicine: Applications to cancer research. Curr. Mol. Med. 10, 640 (2010).
93. J. D. Heidel and M. E. Davis, Clinical developments in nanotechnology for cancer therapy. Pharma. Res. 2, 187 (2011).
94. O. Perumal, B. Michniak-Kohn, E. Touitou, and M. S. Roberts, A special issue on skin nanotechnology. J. Biomedical. Nanotechnol. 6, 405 (2010);
95. J. W. Wiechers and N. Musee, Engineered inorganic nanoparticles and cosmetics: Facts, issues, knowledge gaps and challenges. J. Biomed. Nanotechnol. 6, 408 (2010).
96. A. P. Popov, A. V. Zvyagin, J. Lademann, M. l S. Roberts, W. Sanchez, A. V. Priezzhev, and R. Myllylä, Designing inorganic light-protective skin nanotechnology products. J. Biomed. Nanotechnol. 6, 432 (2010).
97. T. A. Robertson, W. Y. Sanchez, and M. S. Roberts, Are commercially available nanoparticles safe when applied to the skin? J. Biomed. Nanotechnol. 6, 452 (2010).
98. T. G. M. Smijs and J. A. Bouwstra, Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J. Biomed. Nanotechnol. 6, 469 (2010).
99. B. Baroli, Skin absorption and potential toxicity of nanoparticulate nanomaterials. J. Biomed. Nanotechnol. 6, 485 (2010).
100. G. E. J. Poinern, D. Fawcett, Y. J. Ng, N. Ali, R. K. Brundavanam, and Z.-T. Jiang, Nanoengineering a biocompatible inorganic scaffold for skin wound healing. J. Biomed. Nanotechnol. 6, 497 (2010).
101. A. Schroeter, T. Engelbrecht, R. H. H. Neubert, and A. S. B. Goebel, New nanosized technologies for dermal and transdermal drug delivery. A review. J. Biomed. Nanotechnol. 6, 511 (2010).
102. J. Kristl, K. Teska, and P. A. Grabnar, Current view on nanosized solid lipid carriers for drug delivery to the skin. J. Biomed. Nanotechnol. 6, 529 (2010).
103. M. Foldvari, Biphasic Vesicles: A novel topical drug delivery system. J. Biomed. Nanotechnol. 6, 543 (2010).
104. D. Ainbinder, D. Paolino, M. Fresta, and E. Touitou, Drug delivery applications with ethosomes. J. Biomed. Nanotechnol. 6, 558 (2010).
105. M. Shumilov, R. Bercovich, S. Duchi, D. Ainbinder, and E. Touitou, Ibuprofen transdermal ethosomal gel: Characterization and efficiency in animal models. J. Biomed. Nanotechnol. 6, 569 (2010).
106. M. Chen, X. Liu, and A. Fahr, Skin delivery of ferulic acid from different vesicular systems. J. Biomed. Nanotechnol. 6, 577 (2010).
107. T. Gratieri, U. F. Schaefer, L. Jing, M. Gao, K.-H. Kostka, R. F. V. Lopez, and M. Schneider, Penetration of quantum dot particles through human skin. J. Biomed. Nanotechnol. 6, 586 (2010).
108. L. J. Mortensen, S. Ravichandran, H. Zheng, and L. A. DeLouise, Progress and challenges in quantifying skin permeability to nanoparticles using a quantum dot model. J. Biomed. Nanotechnol. 6, 596 (2010).
109. Z. Zhou, S. Joslin, A. Dellinger, M. Ehrich, B. Brooks, Q. Ren, U. Rodeck, R. Lenk, and C. L. Kepley, A novel class of compounds with cutaneous wound healing properties. J. Biomed. Nanotechnol. 6, 605 (2010).
110. Y.-C. Kim, P. J. Ludovice, and M. R. Prausnitz, Transdermal delivery enhanced by antimicrobial peptides. J. Biomed. Nanotechnol. 6, 612 (2010).
111. G. J. Nohynek, E. K. Dufour, and M. S. Roberts, Nanotechnology, cosmetics and the skin: Is there a health risk? Skin Pharmacol. Physiol. 21, 136 (2008).
112. M. Senzui, T. Tamura, K. Miura, K. Ikarashi, Y. Watanabe, and M. Fujii, Study on penetration of titanium dioxide (TiO(2)) nanoparticles into intact and damaged skin in vitro. J. Toxicol. Sci. 35, 107 (2010).
113. R. R. Patlolla, P. R. Desai, K. Belay, and M. S. Singh, Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 31, 5598 (2010).
114. A. Collins and A. Nasir, Nanotechnology and dermatology: Benefits and pitfalls. G. Ital. Dermatol Venereol. 146, 115 (2011).
115. V. Sharma, S. K. Singh, D. Anderson, D. J. Tobin, and A. Dhawan, Zinc oxide nanoparticle induced genotoxicity in primary human epidermal keratinocytes. J. Nanosci. Nanotechnol. 11, 3782 (2011).
116. S. Maiti, Nanotoxicity of gold and iron nanoparticles. J. Biomed. Nanotechnol. 7, 65 (2011).
117. T. Gratieri, U. F. Schaefer, L. Jing, M. Gao, K.-H. Kostka, R. F. V. Lopez, and M. Schneider, Penetration of quantum dot particles through human skin. J. Biomed. Nanotechnol. 6, 586 (2010).
118. Y. L. Zhao and H. S. Nalwa (eds.), Nanotoxicology-Interactions of Nanomaterials with Biological Systems, American Scientific Publishers, Los Angeles (2007).
119. S. Singh and H. S. Nalwa, Nanotechnology and health safety - toxicity and risk assessments of nanostructured materials on human health, J. Nanosci. Nanotechnol. 7, 3048 (2007).
120. A. Dhawan, A. Pandey, and V. Sharma, Toxicity assessment of engineered nanomaterials: Resolving the challenges, J. Biomed. Nanotechnol. 7, 6 (2011).
121. M. Jenny, S. Schroecksnadel, and D. Fuchs, Testing for immunomodulatory properties of nanoparticles. J. Biomed. Nanotechnol. 7, 11 (2011).
122. M. Das, K. M. Ansari, A. Tripathi, and P. D. Dwivedi, Need for safety of nanoparticles used in food industry. J. Biomed. Nanotechnol. 7, 13 (2011).
123. P. van Broekhuizen, Dealing with uncertainties in the nanotech workplace practice: Making the precautionary approach operational. J. Biomed. Nanotechnol. 7, 15 (2011).
124. G. van der Laan, Tracing new occupational diseases in nanoworkers. J. Biomed. Nanotechnol. 7, 18 (2011).
125. H. Norppa, J. Catalán, G. Falck, K. Hannukainen, K. Siivola, and K. Savolainen Nano-specific genotoxic effects. J. Biomed. Nanotechnol. 7, 19 (2011).
126. M. Zuzana, R. Alessandra, F. Lise, and D. Maria, Safety assessment of nanoparticles cytotoxicity and genotoxicity of metal nanoparticles in vitro. J. Biomed. Nanotechnol. 7, 20 (2011).
127. 2nanoparticles on A549 cells. J. Biomed. Nanotechnol. 7, 22 (2011).
128. 2 nanoparticle in media of biological interest for the culture of eukaryotic cells. J. Biomed. Nanotechnol. 7, 24 (2011).
129. I. F. Osman, B. K. Jacob, and D. Anderson, Effect of nanoparticles on human cells from healthy individuals and patients with respiratory diseases. J. Biomed. Nanotechnol. 7, 26 (2011).
130. M. Lotti, Individual exposure to particulate matter and heart rate variability (HRV) in patients with previous myocardial infarction. J. Biomed. Nanotechnol. 7, 28 (2011).
131. H. Wallin, N. R. Jacobsen, P. A. White, J. Gingerich, P. Møller, S. Loft, and U. Vogel, Mutagenicity of carbon nanomaterials. J. Biomed. Nanotechnol. 7, 29 (2011).
132. S. K. Singh, M. K. Singh, M. K. Nayak, S. Kumari, J. J. A. Grácio, and D. Dash, Characterization of graphene oxide by flow cytometry and assessment of its cellular toxicity. J. Biomed. Nanotechnol. 7, 30 (2011).
133. 2. Review of in vivo data. Environ, Pollut. 159, 677 (2011).
134. I. Ahmad, Nanotoxicity of natural minerals: An emerging area of nanotoxicology. J. Biomed. Nanotechnol. 7, 32 (2011).
135. V. Pokharkar, D. Bhumkar, K. Suresh, Y. Shinde, S. Gairola, and S. S. Jadhav, Gold Nanoparticles as a potential carrier for transmucosal vaccine delivery. J. Biomed. Nanotechnol. 7, 57 (2011).
136. S. Kalmodia, V. Sharma, A. K. Pandey, A. Dhawan, and B. Basu, Cytotoxicity and genotoxicity property of hydroxyapatite-mullite eluates. J. Biomed. Nanotechnol. 7, 74 (2011).
137. R. K. Shukla, A. Kumar, A. K. Pandey, S. S. Singh, and A. Dhawan, Titanium dioxide nanoparticles induce oxidative stress-mediated apoptosis in human keratinocyte cells. J. Biomed. Nanotechnol. 7, 100 (2011).
138. N. V. Srikanth Vallabani, S. Mittal, R. K. Shukla, A. K. Pandey, S. R. Dhakate, R. Pasricha, and A. Dhawan, Toxicity of graphene in normal human lung cells (BEAS-2B). J. Biomed. Nanotechnol. 7, 106 (2011).
139. S. Mittal, V. Sharma, N. V. Srikanth Vallabani, S. Kulshrestha, A. Dhawan, and A. K. Pandey, Toxicity evaluation of carbon nanotubes in normal human bronchial epithelial cells. J. Biomed. Nanotechnol. 7, 108 (2011).
140. P. D. Dwivedi, A. Tripathi, K. M. Ansari, R. Shanker, and M. Das, Impact of nanoparticles on the immune system. J. Biomed. Nanotechnol. 7, 193 (2011).
141. J. W. Wiechers and N. Musee, Engineered inorganic nanoparticles and cosmetics: Facts, issues, knowledge gaps and challenges. J. Biomed. Nanotechnol. 6, 408 (2010).
142. World Health Organization: www.who.int/cancer.
143. WHO Tobacco Free Initiative: www.who.int/tobacco.
144. International Agency for Research on Cancer: www.iarc.fr.
145. International Union Against Cancer: www.uicc.org.
146. Cancer Information (Researcher and patient): www.cancerweb.ncl.ac.uk.
147. Nanotechnology Characterization Lab www.ncl.cancer.gov.
148. National Institutes of Health: http://nihroadmap.nih.gov/nanomedicine.
149. National Cancer Institute: http://nano.cancer.gov.